Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,763.96
(
-0.13%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
104.23
(
-0.20%
)
Bitcoin
70,109.41
(
0.30%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: corpstrat post# 79645

Wednesday, 06/17/2009 1:13:57 PM

Wednesday, June 17, 2009 1:13:57 PM

Post# of 257262
Intron-A is essentially obsolete, although it still has modest sales in poorer countries, where its lower price relative to Pegasys and Pegintron is an advantage.

This is the 2001 PR announcing ITMN’s license of Infergen from AMGN:
http://sec.gov/Archives/edgar/data/1087432/000091205701520151/a2052097zex-99_1.htm


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today